683 Capital Management »

Maia Biotechnology shares owned by 683 Capital Management

Quarter-by-quarter ownership of Maia Biotechnology (MAIA) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Maia Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Maia Biotechnology held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maia Biotechnology by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 1.1M 1.40

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
NVIDIA Corporation Put Option (NVDA)
Capital One Financial (COF)
Alnylam Pharmaceuticals (ALNY)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Tesla Motors Put Option (TSLA)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Praxis Precision Medicines I Com New Put Option (PRAX)
Wave Life Sciences SHS (WVE)
Becton, Dickinson and (BDX)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Maia Biotechnology

Alyeska Investment Group
Vanguard Capital Management
Vanguard Group
683 Capital Management
Centric Wealth Management
Cable Car Capital
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Corsair Capital Management
State Street Corporation
UBS Group
Northern Trust
Bridgeway Capital Management
Creative Planning

View all funds holding Maia Biotechnology